Copied to clipboard!

NoSarC -- Norwegian Sarcoma Consortium. Towards individualized therapy for orphan cancer.

This study is initiated and conducted by the Norwegian Sarcoma Consortium - a collaboration between 5 Norwegian hospitals and universities, coordinated by Oslo University Hospital. The NoSarC project was initiated in 2014 and aimed to perform molecular characterization of samples from a national, population-based cohort of sarcoma patients, to identify tumors which are sensitive to therapies already developed and approved for more common cancers. The NoSarC cohort in this study consists of Tumor-Normal pairs from 287 subjects that has been Whole Exome Sequenced.

Type: Exome Sequencing
Archive: Federated EGA Norway Federated EGA Node

1 Dataset

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID	Description	Technology	Samples
EGAD50000003102	The dataset consist of Whole Exome Sequencing results from 287 sarcoma patients in the NoSarC cohort, from which matched sarcoma tumor samples and normal blood samples where pairwise analysed together using the Dragen v.3.7 analysis framework. The dataset contains fastq files as used for input to the analysis and the Dragen 3.7 vcfs outputs for germline mutations, somatic mutations and copy number variants (and their corresponding index files). The phenotype information provided includes: age, sex, times of birth, surgery, death, last followup or last known alive, local recurrence assessment, metastatic-free survival assessment and reccurence-free survival assessment. All times provided in a month-year format. 8 disease and topography fields such as disease status at inclusion, time of WES tumor sampling and final histological diagnosis, as well as tumor lesion sampled and localization of the sarcoma in final diagnosis, are inluced, as well as 5 outcome-related variables incl overall survival and cause of death. Finally 5 treatment-related variables are included. Due to high sequencing depth in several samples, the provided fastq files is the result of a screening process and downsampling if nessearcy, done before the Dragen analysis. The procedure is documented in the included README_fastq_downsampling.txt	Illumina HiSeq 4000	582